<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93981">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01772355</url>
  </required_header>
  <id_info>
    <org_study_id>core biopsy of orbital tumors</org_study_id>
    <nct_id>NCT01772355</nct_id>
  </id_info>
  <brief_title>Effectiveness and Possible Complications of Core Needle Biopsy of Orbital Tumors</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yarovoy Andrey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The S.N. Fyodorov Eye Microsurgery State Institution</source>
  <oversight_info>
    <authority>Russia: Ministry of Health of the Russian Federation</authority>
    <authority>United States: Federal Government</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Core needle biopsy of orbital mass lesions with a semiautomated needles is a safe procedure
      that provides a sufficient amount of tissue material for standard histological and
      immunohistochemical analysis and can be an alternative or supplement to fine needle
      aspiration biopsy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>true identification of an orbital tumor with a core needle biopsy</measure>
    <time_frame>five years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Orbial Mass Lesion</condition>
  <arm_group>
    <arm_group_label>tissue core</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>semi automated core needle biopsy of the orbital tumors</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>semi automated core needle biopsy of orbital tumors</intervention_name>
    <arm_group_label>tissue core</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unresectable mass lesions with diffuse involvement of the orbit or the tumors with
             infiltrative growth and indistinct borders which needed to have morphologic
             verification

        Exclusion Criteria:

          -  An anti-coagulant therapy at the time of biopsy,

          -  bleeding diathesis,

          -  suspected hypervascular lesions,

          -  orbital roof destruction with a tumor,

          -  apical location of the tumor
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrey A Yarovoy, MD</last_name>
    <phone>+74994888943</phone>
    <email>yarovoyaa@yandex.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>The S.Fyodorov Eye Microsurgery Federal State Institution</name>
      <address>
        <city>Moscow</city>
        <zip>127486</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrey A Yarovoy, MD</last_name>
      <phone>+74994888943</phone>
      <email>yarovoyaa@yandex.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 17, 2013</lastchanged_date>
  <firstreceived_date>January 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The S.N. Fyodorov Eye Microsurgery State Institution</investigator_affiliation>
    <investigator_full_name>Yarovoy Andrey</investigator_full_name>
    <investigator_title>MD, PhD, head ocular oncology department</investigator_title>
  </responsible_party>
  <keyword>orbit; tumor; core biopsy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
